You must be 21 years or older to access this website. All products are for research use only.
Are you 21 years of age or older?
By entering, you confirm that you are at least 21 years old and agree to our terms of service.

Volume Discount
8% off
$150+ cart
12% off
$250+ cart
18% off
$400+ cart
Third-Party Tested
Independent lab verification
COA Available
Certificate of Analysis included
Free Shipping
On all domestic orders
Research Use Only
For laboratory research purposes
GLP-2 TZ is a research peptide for laboratory investigation of GLP-2 receptor pathways. Each vial contains 30mg of lyophilized peptide for research purposes only. Third-party tested with Certificate of Analysis (COA) available. Purity: >99%. COA Batch: Midw2512010132.
GLP-2 TZ is a research-only compound designed for scientific investigation involving GLP-1 and GIP receptor pathways.
This compound is offered solely for in vitro laboratory research. It is not intended for diagnostic, therapeutic, or clinical use in humans or animals. Not for dietary, cosmetic, or veterinary applications. This product has not been evaluated by the FDA or any medical body.
All information provided is strictly educational. No claim of efficacy or safety is made. Buyers assume full responsibility for ensuring proper use under federal and local research guidelines.
By purchasing from Midwest Peptide, you affirm that you are a qualified researcher with the experience to safely handle and store research materials. All sales are final. The supplier is not liable for any misuse, misrepresentation, or unintended outcomes related to this product.
GLP-2 TZ is a research peptide also known as tirzepatide, a 39-amino-acid synthetic dual agonist that activates both GLP-1 and GIP receptors. It is classified as a dual incretin receptor agonist used in metabolic and endocrinology research. Supplied strictly for Research Use Only.
Yes. GLP-2 TZ and tirzepatide refer to the same molecule. The GLP-2 naming reflects its position in the GLP receptor agonist research class (single, dual, triple), while tirzepatide is the international nonproprietary name. Both names map to the identical 39-residue sequence.
GLP-2 TZ activates two receptors (GLP-1 and GIP) while GLP-1 SM activates only the GLP-1 receptor. Research models show the dual-receptor mechanism produces stronger effects on glucose handling and adipose tissue endpoints than single-receptor agonists.
Other research peptides in this category
Research articles and insights related to GLP-2 TZ

FDA restricted compounded tirzepatide for human use when the shortage ended. The Research Use Only research peptide channel for tirzepatide (GLP-2 TZ) operates under entirely separate regulations.
May 5, 2026

The cheapest tirzepatide (GLP-2 TZ) for research is rarely the best value. Here is how to balance price against the analytical specifications that determine research utility.
May 5, 2026

GLP-2 TZ (tirzepatide) inflammation research covering circulating inflammatory markers, adipose inflammation, hepatic inflammation, and vascular inflammation. For research use only.
April 24, 2026

GLP-2 TZ (tirzepatide) kidney research covering dual receptor renal protection, diabetic kidney disease, and podocyte biology. For research use only.
April 24, 2026
Research Use Only. These products are not supplements, drugs, or intended for human or veterinary use. These products are for laboratory research purposes only. All product information available on this website is for educational purposes only. The products offered on this website are not intended to diagnose, treat, cure, or prevent any disease. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This material is sold for in-vitro research purposes only.
Research Use Only. This product is intended solely for laboratory research purposes. Not for human or veterinary use. Not for food or cosmetic use. By purchasing, the buyer agrees to use this product only for research applications.
SKU: MPGLP2
GLP-2 TZ (also written GLP2TZ, GLP-2-TZ, GLP-TZ, or by its INN Tirzepatide) is a dual GLP-1/GIP receptor agonist research peptide. 30mg lyophilized vial. Every batch ships with a third-party Certificate of Analysis showing HPLC purity above 98% and mass spec identity confirmation. For laboratory and in-vitro research only.
GLP-2 TZ is a dual GLP-1 / GIP receptor agonist. GLP-3 RT is a triple GLP-1 / GIP / glucagon receptor agonist. The added glucagon-receptor activity of GLP-3 RT distinguishes the two in research models studying energy expenditure and lipid metabolism.
GLP-2 TZ is used in preclinical research on metabolic regulation, glucose homeostasis, body composition partitioning, and incretin pathway pharmacology. All cited studies are conducted in rodent or in-vitro systems consistent with the molecule's RUO classification.
Every batch of GLP-2 TZ ships with a third-party COA verifying purity by HPLC (>=99%), identity by mass spectrometry, and lyophilized mass. The batch-specific COA is published on this product page before purchase.
Lyophilized GLP-2 TZ is stored at -20C for long-term storage and 2-8C for short-term use within 30 days. Avoid repeated freeze-thaw cycles, which can compromise peptide stability. Store in original sealed vials, protected from light.
Tirzepatide (the molecule's INN) has clinical approvals in some indications. The GLP-2 TZ supplied here is for laboratory and research use only and is not approved for diagnostic, therapeutic, or human use.